Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy.

Thomas M, Spigel DR, Jotte RM, McCleod M, Socinski MA, Page RD, Gressot L, Knoble J, Juan O, Morgensztern D, Isla D, Kim ES, West H, Ko A, Ong TJ, Trunova N, Gridelli C.

Lung Cancer (Auckl). 2017 Oct 30;8:207-216. doi: 10.2147/LCTT.S138570. eCollection 2017.

2.
3.

Complementary and Alternative Medicine in Cancer Care.

West HJ.

JAMA Oncol. 2017 Oct 19. doi: 10.1001/jamaoncol.2017.3120. [Epub ahead of print] No abstract available.

PMID:
29049669
4.

A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non-small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations.

Yu HA, Spira A, Horn L, Weiss J, West H, Giaccone G, Evans T, Kelly RJ, Desai B, Krivoshik A, Moran D, Poondru S, Jie F, Aoyama K, Keating A, Oxnard GR.

Clin Cancer Res. 2017 Sep 27. doi: 10.1158/1078-0432.CCR-17-1447. [Epub ahead of print]

PMID:
28954786
5.

Chimeric Antigen Receptor (CAR) T-Cell Therapy.

Pagel JM, West HJ.

JAMA Oncol. 2017 Nov 1;3(11):1595. doi: 10.1001/jamaoncol.2017.2989. No abstract available.

PMID:
28880983
6.

Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials.

West HL, Moon J, Wozniak AJ, Mack P, Hirsch FR, Bury MJ, Kwong M, Nguyen DD, Moore DF, Miao J, Redman M, Kelly K, Gandara DR.

Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30203-6. doi: 10.1016/j.cllc.2017.06.016. [Epub ahead of print]

PMID:
28801183
7.

Chemotherapy-Induced Hair Loss (Alopecia).

West HJ.

JAMA Oncol. 2017 Aug 1;3(8):1147. doi: 10.1001/jamaoncol.2017.1026. No abstract available.

PMID:
28542687
8.

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.

Kim DW, Tiseo M, Ahn MJ, Reckamp KL, Hansen KH, Kim SW, Huber RM, West HL, Groen HJM, Hochmair MJ, Leighl NB, Gettinger SN, Langer CJ, Paz-Ares Rodríguez LG, Smit EF, Kim ES, Reichmann W, Haluska FG, Kerstein D, Camidge DR.

J Clin Oncol. 2017 Aug 1;35(22):2490-2498. doi: 10.1200/JCO.2016.71.5904. Epub 2017 May 5.

PMID:
28475456
9.

A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer.

Wakelee HA, Gettinger S, Engelman J, Jänne PA, West H, Subramaniam DS, Leach J, Wax M, Yaron Y, Miles DR, Lara PN Jr.

Cancer Chemother Pharmacol. 2017 May;79(5):923-932. doi: 10.1007/s00280-017-3283-z. Epub 2017 Mar 28.

10.

Do the Data on Scalp Cooling for Patients With Breast Cancer Warrant Broad Adoption?

West HJ.

JAMA Oncol. 2017 Aug 1;3(8):1130-1131. doi: 10.1001/jamaoncol.2017.0051. No abstract available.

PMID:
28196216
11.

Bringing Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer Into Real-world Practice-Better Late Than Never?

West HJ.

JAMA Oncol. 2017 May 1;3(5):619. doi: 10.1001/jamaoncol.2016.5798. No abstract available.

PMID:
28056130
12.

PS01.53: First-Line Atezolizumab Plus Chemotherapy in Chemotherapy-Naive Patients with Advanced NSCLC: A Phase III Clinical Program: Topic: Medical Oncology.

Jotte RM, Socinski MA, Reck M, Papadimitrakopoulou V, West HJ, Mok T, Sandler A, Mocci S, Coleman S, Asakawa T, Cappuzzo F.

J Thorac Oncol. 2016 Nov;11(11S):S302-S303. doi: 10.1016/j.jtho.2016.09.088. Epub 2016 Oct 28. No abstract available.

13.

Novel Precision Medicine Trial Designs: Umbrellas and Baskets.

West HJ.

JAMA Oncol. 2017 Mar 1;3(3):423. doi: 10.1001/jamaoncol.2016.5299. No abstract available.

PMID:
27930754
14.

Highlights of Recent Studies of Metastatic Non-Small Cell Lung Cancer.

West HJ.

JAMA Oncol. 2016 Oct 6. doi: 10.1001/jamaoncol.2016.3676. [Epub ahead of print] No abstract available.

PMID:
27711928
15.

Intimacy, Body Image, and Cancer.

Bates G, Taub RN, West HJ.

JAMA Oncol. 2016 Dec 1;2(12):1667. doi: 10.1001/jamaoncol.2016.1196. No abstract available.

PMID:
27711916
16.

P1.47: ABOUND.sqm QoL by Response: Interim Analysis of Squamous NSCLC Pts Treated With nab-Paclitaxel/Carboplatin Induction Therapy: Track: Advanced NSCLC.

Langer C, Hirsh V, Amiri KI, Ko A, Knoble J, Johnson M, Jotte R, Mccleod M, Ong TJ, Page R, Spigel D, West HJ, Trunova N.

J Thorac Oncol. 2016 Oct;11(10S):S212-S213. doi: 10.1016/j.jtho.2016.08.069. Epub 2016 Sep 22. No abstract available.

17.

Mucositis (or Stomatitis).

Gupta A, West HJ.

JAMA Oncol. 2016 Oct 1;2(10):1379. doi: 10.1001/jamaoncol.2016.2103. No abstract available.

PMID:
27584707
18.

Can We Define and Reach Precise Goals for Precision Medicine in Cancer Care?

West HJ.

J Clin Oncol. 2016 Aug 1. pii: JCO688226. [Epub ahead of print] No abstract available.

PMID:
27480152
19.

Jaundice (Hyperbilirubinemia) in Cancer.

Subbiah V, West HJ.

JAMA Oncol. 2016 Aug 1;2(8):1103. doi: 10.1001/jamaoncol.2016.1236. No abstract available.

PMID:
27416009
20.

Lymph Nodes and Lymphadenopathy in Cancer.

West H, Jin J.

JAMA Oncol. 2016 Jul 1;2(7):971. doi: 10.1001/jamaoncol.2015.3509. No abstract available.

PMID:
27196692

Supplemental Content

Loading ...
Support Center